Literature DB >> 29678572

Sildenafil protects neuronal cells from mitochondrial toxicity induced by β-amyloid peptide via ATP-sensitive K+ channels.

Yonghae Son1, Koanhoi Kim2, Hyok-Rae Cho3.   

Abstract

To understand the molecular mechanisms underlying the beneficial effects of sildenafil in animal models of neurological disorders, we investigated the effects of sildenafil on the mitochondrial toxicity induced by β-amyloid (Aβ) peptide. Treatment of HT-22 hippocampal neuronal cells with Aβ25∼35 results in increased mitochondrial Ca2+ load, which is subsequently suppressed by sildenafil as well as by diazoxide, a selective opener of the ATP-sensitive K+ channels (KATP). However, the suppressive effects of sildenafil and diazoxide are significantly attenuated by 5-hydroxydecanoic acid (5-HD), a KATP inhibitor. The increased mitochondrial Ca2+ overload is accompanied by decrease in the intracellular ATP concentration, increase in intracellular ROS generation, occurrence of mitochondrial permeability transition, and activation of caspase-9 and cell death. Exposure to sildenafil inhibited the mitochondria-associated changes and cell death induced by Aβ. However, the inhibitory effects of sildenafil are abolished or weakened in the presence of 5-HD, suggesting that opening of the mitochondrial KATP is required for sildenafil to exert these effects. Taken together, these results indicate that at the mitochondrial levels, sildenafil plays a protective role towards neuronal cell in an environment rich in Aβ, and exerts its effects via the mitochondrial KATP channels-dependent mechanisms.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cell death; Neuronal cell; Sildenafil; β-amyloid peptide

Mesh:

Substances:

Year:  2018        PMID: 29678572     DOI: 10.1016/j.bbrc.2018.04.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Decreased gene expression of KACh and KATP channels in hyperthyroid rabbit atria.

Authors:  Feng Zhang; Guang Hai Zhou; Qi An; Jie Yang; Yu Hao Wang; Jia Quan Zhu; Song Nan Jin; Jin Fu Wen
Journal:  Int J Clin Exp Pathol       Date:  2022-03-15

2.  Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease.

Authors:  Jiansong Fang; Pengyue Zhang; Yadi Zhou; Chien-Wei Chiang; Juan Tan; Yuan Hou; Shaun Stauffer; Lang Li; Andrew A Pieper; Jeffrey Cummings; Feixiong Cheng
Journal:  Nat Aging       Date:  2021-12-06

Review 3.  Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist.

Authors:  Giovanni Ribaudo; Alberto Ongaro; Giuseppe Zagotto; Maurizio Memo; Alessandra Gianoncelli
Journal:  ACS Chem Neurosci       Date:  2020-05-28       Impact factor: 4.418

4.  Phosphodiesterase-5 Inhibitor Attenuates Anxious Phenotypes and Movement Disorder Induced by Mild Ischemic Stroke in Rats.

Authors:  Yeon Hee Yu; Seong-Wook Kim; Juhyeon Kang; Yejin Song; Hyuna Im; Seo Jeong Kim; Dae Young Yoo; Man-Ryul Lee; Dae-Kyoon Park; Jae Sang Oh; Duk-Soo Kim
Journal:  J Korean Neurosurg Soc       Date:  2022-04-18

Review 5.  Repurposing Licensed Drugs for Use Against Alzheimer's Disease.

Authors:  Leslie C Norins
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.